Abstract
Background:
Percutaneous vertebroplasty was found to be effective in treating osteoporosis-related compression fractures; it is also useful in treatment of hemangioma, multiple myeloma and metastasis.Objectives:
This study was aimed to evaluate the short term clinical outcome of percutaneous vertebroplasty.Patients and Methods:
Twenty-seven patients were enrolled into this descriptive analytical study after being informed on technical details of procedure and its pre- and post-operative cares. Polymethylmetacrylate bone cement was injected under continuous CT imaging guidance. The amount of injected cement in each treated vertebral body and any cement leakage was monitored.Results:
The mean volume of injected cement was 6.22 2.24 (210) mL. The baseline, immediately after procedure and one week and one month post procedure pain scores were 8.11 1.69 7.85 1.59, 6.30 1.66 and 3.63 1.50, respectively. The pain was significantly reduced gradually after the procedure (P < 0.001). The baseline and immediately after procedure and one week and one month post procedure disability scores were 78.70 9.05, 58.52 13.99, 47.96 14.95, and 37.59 18.87, respectively. The disability significantly faded after the procedure (P < 0.001).Conclusions:
Percutaneous vertebroplasty is an efficient technique with low complication rates and a significant reduction in pain.Full Text
Full text is available in PDF
Copyright
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.